{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:08:30Z","timestamp":1783818510569,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05265-3","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:22:55Z","timestamp":1783758175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of MRI PI-RADS 3 lesions upgraded by dynamic contrast enhancement: the \u201cPI-RADS 3\u2009+\u20091\u201d subgroup"],"prefix":"10.1007","author":[{"given":"Margaux","family":"Poniman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Imzourh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Bened","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chemouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0344-2237","authenticated-orcid":false,"given":"Thibaut","family":"Long Depaquit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"5265_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"5265_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R, Claudon M, Roy C, M\u00e8ge-Lechevallier F et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109","journal-title":"Lancet Oncol"},{"key":"5265_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"5265_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2024.102853","volume":"35","author":"T Long Depaquit","year":"2025","unstructured":"Long Depaquit T, Uleri A, Peyrottes A, Corral R, Toledano H, Chiron P et al (2025) PI-RADS 3 MRI lesions: are biopsies still necessary? Fr J Urol 35:102853","journal-title":"Fr J Urol"},{"key":"5265_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-025-01986-2","volume":"25","author":"T Franz","year":"2025","unstructured":"Franz T, Sicker T, Lueke J, Dinh B, Ho TP, Spinos T et al (2025) To biopsy or not biopsy, that is the question - PI-RADS 3 prostate lesions \u2013 validation of clinical and radiological parameters for biopsy decision-making. BMC Urol 25:274","journal-title":"BMC Urol"},{"key":"5265_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejrad.2017.08.017","volume":"95","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Koo BC, Warren AY, Kastner C, Barrett T (2017) Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection. Eur J Radiol 95:307\u2013313","journal-title":"Eur J Radiol"},{"key":"5265_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","volume":"67","author":"EHJ Hamoen","year":"2015","unstructured":"Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM (2015) Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 67:1112\u20131121","journal-title":"Eur Urol"},{"key":"5265_CR8","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jama.2025.13722","volume":"334","author":"ABCD Ng","year":"2025","unstructured":"Ng ABCD, Asif A, Agarwal R, Panebianco V, Girometti R, Ghai S et al (2025) Biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA 334:1170\u20131179","journal-title":"JAMA"},{"key":"5265_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bju.14759","volume":"124","author":"M Alabousi","year":"2019","unstructured":"Alabousi M, Salameh J-P, Gusenbauer K, Samoilov L, Jafri A, Yu H et al (2019) Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-na\u00efve patients: a diagnostic test accuracy systematic review and meta-analysis. BJU Int 124:209\u2013220","journal-title":"BJU Int"},{"key":"5265_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bju.13465","volume":"119","author":"S Washino","year":"2017","unstructured":"Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients. BJU Int 119:225\u2013233","journal-title":"BJU Int"},{"key":"5265_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, van den Broeck T, Brunckhorst O, Darraugh J et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163","journal-title":"Eur Urol"},{"key":"5265_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA et al (2016) International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244\u2013252","journal-title":"Am J Surg Pathol"},{"key":"5265_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bju.14640","volume":"123","author":"M Assel","year":"2019","unstructured":"Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A et al (2019) Guidelines for reporting of statistics for clinical research in urology. BJU Int 123:401\u2013410","journal-title":"BJU Int"},{"key":"5265_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/tau.2017.12.31","volume":"7","author":"IG Schoots","year":"2018","unstructured":"Schoots IG (2018) MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol 7:70\u201382","journal-title":"Transl Androl Urol"},{"key":"5265_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2026.01.030","author":"G Strieder de Oliveira","year":"2026","unstructured":"Strieder de Oliveira G, Altmayer S, Torri GB, Prediger JE, Abreu-Gomez J, Ghai S et al (2026) Diagnostic performance of biparametric versus multiparametric magnetic resonance imaging for prostate cancer diagnosis: an updated systematic review and meta-analysis. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2026.01.030","journal-title":"Eur Urol"},{"key":"5265_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","volume":"24","author":"EJ Bass","year":"2021","unstructured":"Bass EJ, Pantovic A, Connor M, Gabe R, Padhani AR, Rockall A et al (2021) A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis 24:596\u2013611","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5265_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Kozarek J, Russell R, Drescher M, Khan A, Kundra V et al (2024) Diagnostic performance of PSA density for detecting clinically significant prostate cancer in the era of MRI: a systematic review and meta-analysis. Eur Urol Oncol 7:189\u2013203","journal-title":"Eur Urol Oncol"},{"key":"5265_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.2020192133","volume":"296","author":"KJ Park","year":"2020","unstructured":"Park KJ, Kim M-H, Kim JK (2020) Extraprostatic tumor extension: comparison of preoperative multiparametric MRI criteria and histopathologic correlation after radical prostatectomy. Radiology 296:87\u201395","journal-title":"Radiology"},{"key":"5265_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","volume":"4","author":"E Mazzone","year":"2021","unstructured":"Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO et al (2021) Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol 4:697\u2013713","journal-title":"Eur Urol Oncol"},{"key":"5265_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.prnil.2020.10.001","volume":"9","author":"JL Marenco Jimenez","year":"2021","unstructured":"Marenco Jimenez JL, Claps F, Ram\u00f3n-Borja JC, Mascar\u00f3s Martinez JM, Gutierrez AW, Lozano \u00c1GF et al (2021) Rebiopsy rate after transperineal or transrectal prostate biopsy. Prostate Int 9:78\u201381","journal-title":"Prostate Int"},{"key":"5265_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.euo.2023.11.008","volume":"7","author":"JP Buteau","year":"2024","unstructured":"Buteau JP, Moon D, Fahey MT, Roberts MJ, Thompson J, Murphy DG et al (2024) Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography\/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. Eur Urol Oncol 7:544\u2013552","journal-title":"Eur Urol Oncol"},{"key":"5265_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ et al (2021) The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol 80:682\u2013689","journal-title":"Eur Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05265-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:02:11Z","timestamp":1783818131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05265-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":22,"alternative-id":["5265"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05265-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}